Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
Tvisha Subhasish, Research Specialist – Department of Surgery at University of Pittsburgh School of Medicine, shared a post on LinkedIn about a recent article she and Christopher Reed co-authored, published in Research and Practice in Thrombosis and Haemostasis, adding:
”Proud to share my first first-author paper!
‘Extravascular Factor IX: A Semicentennial Narrative Review’ is now out in RPTH Journal.
Despite decades of research, there are major unanswered questions about extravascular Factor IX. In this review, we highlight research updates on extravascular Factor IX since 2020, and present remaining questions to help guide future investigations.
Thank you to my mentors Dr. Christopher Reed, Matthew D. Neal and Susan Shea for their support and guidance in this work. Your input and encouragement at Pittsburgh Trauma and Transfusion Medicine Research Center have been invaluable.
I’m looking forward to continuing our own work quantifying extravascular Factor IX dynamics in traumatic injury animal models and sharing our findings in the coming months.”
Title: Extravascular Factor IX: A Semicentennial Narrative Review
Authors: Tvisha Subhasish, Christopher Reed
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?
-
Sep 3, 2026, 10:42Jared Griffard: Hemorrhagic Shock and Component Blood Transfusion
-
Sep 3, 2026, 10:31Alan Nurden: Comparing Antiplatelet and Antithrombin Therapies in Coronary Microcirculation
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease